Acute high-risk pulmonary embolism requiring thrombolytic therapy in a COVID-19 pneumonia patient despite intermediate dosing deep vein thromboprophylaxis

Acute high-risk pulmonary embolism requiring thrombolytic therapy in a COVID-19 pneumonia patient despite intermediate dosing deep vein thromboprophylaxis

Cytokine storm induced by the coronavirus 19 (COVID-19) profoundly activates the coagulation cascade causing venous thromboembolism (VTE). Initial studies from Wuhan, China showed increased incidence of VTE in patients with no standard deep vein thrombosis (DVT) prophylaxis in COVID-19 pneumonia pat...

Full description

Bibliographic Details
Main Authors: Shameen Salam, Jihad Mallat, Hussam Elkambergy
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Pulmonary embolism
COVID-19
Thrombolytic therapy
DVT prophylaxis
Venous thromboembolism
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007120304779

Internet

http://www.sciencedirect.com/science/article/pii/S2213007120304779

Similar Items